Developing next-generation antibody-drug conjugates for breast cancer drug delivery: hurdles and advances in the clinic.
This review synthesizes literature spanning 1990-2026 on advances in ADC design and their clinical and translational implementation in breast cancer to support reframing antigen selection as a system-level challenge, supported by delivery-focused engineering, precision-medicine-driven trial design, and adaptive methodo...